H. Löo

1.2k total citations
51 papers, 838 citations indexed

About

H. Löo is a scholar working on Psychiatry and Mental health, Pharmacology and Biological Psychiatry. According to data from OpenAlex, H. Löo has authored 51 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 7 papers in Biological Psychiatry. Recurrent topics in H. Löo's work include Bipolar Disorder and Treatment (10 papers), Attention Deficit Hyperactivity Disorder (7 papers) and Tryptophan and brain disorders (7 papers). H. Löo is often cited by papers focused on Bipolar Disorder and Treatment (10 papers), Attention Deficit Hyperactivity Disorder (7 papers) and Tryptophan and brain disorders (7 papers). H. Löo collaborates with scholars based in France, Canada and United Kingdom. H. Löo's co-authors include Marie‐Odile Krebs, A. Galinowski, E. Zarifian, M F Poirier, D Ginestet, F. Homo‐Delarche, J F Bach, Lucienne Chatenoud, Marie Poirier and M.-C. Bourdel and has published in prestigious journals such as American Journal of Psychiatry, Brain and Molecular Psychiatry.

In The Last Decade

H. Löo

48 papers receiving 800 citations

Peers

Countries citing papers authored by H. Löo

Since Specialization

Citations

This map shows the geographic impact of H. Löo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Löo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Löo more than expected).

Fields of papers citing papers by H. Löo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Löo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Löo. The network helps show where H. Löo may publish in the future.

Co-authorship network of co-authors of H. Löo

This figure shows the co-authorship network connecting the top 25 collaborators of H. Löo. A scholar is included among the top collaborators of H. Löo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Löo. H. Löo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of diagnostic algorithm for Cushing’s syndrome: a tertiary centre experience 2024 ·Journal of Endocrinological Investigation ·(unknown), H. Löo, (unknown), Tim James, Brian Keevil, Jeremy Tomlinson, Aparna Pal, Riccardo Pofi	4
2	Astrocytic TYMP and VEGFA drive blood–brain barrier opening in inflammatory central nervous system lesions 2015 ·Brain ·Candice Chapouly, Azeb Tadesse Argaw, Sam Horng, Kamilah Castro, Jingya Zhang, Linnéa Asp, H. Löo, Benjamin M. Laitman, John N. Mariani, Rebecca Straus Farber, Elena Zaslavsky, German Nudelman, Cedric S. Raine, Gareth John	130
3	Traitement par électroconvulsivothérapie d’une tétraplégie par conversion hystérique : à propos d’un cas 2011 ·L Encéphale ·(unknown), Raphaël Gaillard, Fayçal Mouaffak, (unknown), H. Löo	9
4	Tumour Shrinkage and Contour Change during Radiotherapy Increase the Dose to Organs at Risk but not the Target Volumes for Head and Neck Cancer Patients Treated on the TomoTherapy HiArt™ System 2010 ·Clinical Oncology ·H. Löo, J. Fairfoul, Annie Chakrabarti, (unknown), Richard Benson, S. Jefferies, N.G. Burnet	43
5	Double‐blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteers 2004 ·Human Psychopharmacology Clinical and Experimental ·Marie Poirier, A. Galinowski, I. Amado, (unknown), (unknown), A. Tournoux, C. Serre, H. Löo	13
6	Phenomenological and comorbid features associated in obsessive–compulsive disorder: influence of age of onset 2002 ·Journal of Affective Disorders ·Bruno Millet, F. Kochman, Thierry Gallarda, Marie‐Odile Krebs, (unknown), (unknown), M.-C. Bourdel, Jean‐Pierre Olié, H. Löo, Élie Hantouche	110
7	[Effects of sulbutiamine (Arcalion 200) on psycho-behavioral inhibition in major depressive episodes]. 2000 ·PubMed ·H. Löo, M F Poirier, (unknown), (unknown)	7
8	Genetic vulnerability to drug abuse 2000 ·European Psychiatry ·(unknown), Marie‐Odile Krebs, H. Löo, Marie Poirier	47
9	Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence 1998 ·Molecular Psychiatry ·(unknown), Philip Gorwood, Nathalie Griffon, (unknown), François Sautel, Pierre Sokoloff, (unknown), J. Adès, H. Löo, M F Poirier	75
10	[Münchhausen syndrome by proxy between two adults]. 1996 ·PubMed ·Marie‐Odile Krebs, Asma Bouden, H. Löo, (unknown)	9
11	Treatment of depressive syndromes in detoxified drug addicts: use of methadone 1996 ·Biomedicine & Pharmacotherapy ·Xavier Laqueille, F.-J. Baylé, C. Spadone, (unknown), H. Löo	6
12	A double-blind comparison of tianeptine, imipramine and placebo in the treatment of major depressive episodes 1996 ·European Psychiatry ·Gb Cassano, Gerardo Heinze, H. Löo, J. Mendlewicz, (unknown)	25
13	[The risk of depression]. 1995 ·PubMed ·J P Olié, H. Löo	1
14	Comparison of acetorphan with clonidine for opiate withdrawal symptoms 1991 ·American Journal of Psychiatry ·Frank Hartmann, (unknown), M.-C. Bourdel, H. Löo, J Lecomte, J.C. Schwartz	19
15	Diagnostic and therapeutic value of testing stimulation of thyroid‐stimulating hormone by thyrotropin‐releasing hormone in 100 depressed patients 1990 ·Acta Psychiatrica Scandinavica ·Jean‐Marie Vanelle, M F Poirier, Chawki Benkelfat, A. Galinowski, D. Sechter, (unknown), H. Löo	14
16	[Lithium poisoning. 2 unpublished interactions: acetazolamide and niflumic acid]. 1986 ·PubMed ·Caryl Gay, (unknown), (unknown), Jean‐Pierre Olié, H. Löo	1
17	Lithium, sodium and potassium transport in erythrocytes of manic‐depressive patients 1984 ·Acta Psychiatrica Scandinavica ·Georges Dagher, C. C. GAY, (unknown), (unknown), J.-P. Olié, Ricardo P. Garay, H. Löo, Philippe Meyer	13
18	Intellectual efficiency in manic‐depressive patients treated with lithium 1981 ·Acta Psychiatrica Scandinavica ·H. Löo, (unknown), P. Etévenon, Jalil Benyacoub, (unknown)	10
19	Measurement of the Plasmatic Level of Free and Protein-Bound Tryptophan in Mental Pathology 1980 ·Neuropsychobiology ·(unknown), H. Löo, E. Zarifian, (unknown), (unknown), Carlos Escande, Bernard Bousquet, C Dreux	2
20	[A new psychotropic drug: carpipramine, intermediate compound between 2 therapeutic classes]. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·P Deniker, H. Löo, E. Zarifian, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact